Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways

Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways

Item
http://www.wikidata.org/entity/Q27315022
Human tumor xenograft models for preclinical assessment of anticancer drug development.Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.Saraca indica bark extract shows in vitro antioxidant, antibreast cancer activity and does not exhibit toxicological effects.A disintegrin and metalloprotease 17 promotes microglial cell survival via epidermal growth factor receptor signalling following spinal cord injury.High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts.Paclitaxel induces apoptosis and reduces proliferation by targeting epidermal growth factor receptor signaling pathway in oral cavity squamous cell carcinomaThe role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.Anticipating mechanisms of resistance to PI3K inhibition in breast cancer: a challenge in the era of precision medicine.Identification of gallic acid based glycoconjugates as a novel tubulin polymerization inhibitors.
P2860

Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways

Item
http://www.wikidata.org/entity/Q27315022
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Chemotherapeutic Potential of ...... FOXO and MEK/Erk/AP-1 Pathways
@ast
Chemotherapeutic Potential of ...... FOXO and MEK/Erk/AP-1 Pathways
@en
Chemotherapeutic Potential of ...... FOXO and MEK/Erk/AP-1 Pathways
@nl
type
label
Chemotherapeutic Potential of ...... FOXO and MEK/Erk/AP-1 Pathways
@ast
Chemotherapeutic Potential of ...... FOXO and MEK/Erk/AP-1 Pathways
@en
Chemotherapeutic Potential of ...... FOXO and MEK/Erk/AP-1 Pathways
@nl
prefLabel
Chemotherapeutic Potential of ...... FOXO and MEK/Erk/AP-1 Pathways
@ast
Chemotherapeutic Potential of ...... FOXO and MEK/Erk/AP-1 Pathways
@en
Chemotherapeutic Potential of ...... FOXO and MEK/Erk/AP-1 Pathways
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Chemotherapeutic Potential of ...... FOXO and MEK/Erk/AP-1 Pathways
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0066246
P407
P433
P478
P50
P577
P5875
P698
P921
P932